DD216005A5 - Verfahren zur herstellung von pyrrolidinonderivaten - Google Patents
Verfahren zur herstellung von pyrrolidinonderivaten Download PDFInfo
- Publication number
- DD216005A5 DD216005A5 DD84259606A DD25960684A DD216005A5 DD 216005 A5 DD216005 A5 DD 216005A5 DD 84259606 A DD84259606 A DD 84259606A DD 25960684 A DD25960684 A DD 25960684A DD 216005 A5 DD216005 A5 DD 216005A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- compound
- hydrogen
- acid
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH45383 | 1983-01-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD216005A5 true DD216005A5 (de) | 1984-11-28 |
Family
ID=4187370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD84259606A DD216005A5 (de) | 1983-01-27 | 1984-01-25 | Verfahren zur herstellung von pyrrolidinonderivaten |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0115472A3 (cs) |
JP (1) | JPS59141559A (cs) |
KR (1) | KR840007571A (cs) |
AU (1) | AU2383884A (cs) |
DD (1) | DD216005A5 (cs) |
DK (1) | DK35884A (cs) |
FI (1) | FI840260A7 (cs) |
GR (1) | GR81746B (cs) |
IL (1) | IL70772A0 (cs) |
NO (1) | NO840310L (cs) |
PT (1) | PT78007B (cs) |
ZA (1) | ZA84560B (cs) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE943625C (de) * | 1943-06-28 | 1956-05-24 | Ferguson Harry Inc | Seitensteuerungseinrichtung fuer ein landwirtschaftliches Schlepperanbaugeraet |
JPH0696574B2 (ja) * | 1987-09-16 | 1994-11-30 | 三菱化成株式会社 | 4−ピペリジンカルボキサミド誘導体 |
JPH0696575B2 (ja) * | 1987-09-17 | 1994-11-30 | 三菱化成株式会社 | 4−アミノピリジン誘導体及びその酸付加塩 |
JP2997488B2 (ja) * | 1989-12-25 | 2000-01-11 | 興研株式会社 | 腫瘍細胞増殖抑制剤 |
US5576293A (en) * | 1993-09-30 | 1996-11-19 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP1159273A1 (en) | 1999-03-02 | 2001-12-05 | Boehringer Ingelheim Pharmaceuticals Inc. | Compounds useful as reversible inhibitors of cathepsin s |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
US6825229B2 (en) | 2002-03-07 | 2004-11-30 | Blanchette Rockefeller Neurosciences Institute | Methods for Alzheimer's Disease treatment and cognitive enhancement |
US20050065205A1 (en) | 2002-03-07 | 2005-03-24 | Daniel Alkon | Methods for Alzheimer's disease treatment and cognitive enhance |
TW201206425A (en) | 2004-05-18 | 2012-02-16 | Brni Neurosciences Inst | Treatment of depressive disorders |
WO2007016202A1 (en) | 2005-07-29 | 2007-02-08 | Blanchette Rockefeller Neurosciences Institute | Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory |
EP2754448A3 (en) | 2007-02-09 | 2014-12-24 | Blanchette Rockefeller Neurosciences, Institute | Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT360980B (de) * | 1976-01-14 | 1981-02-10 | Pliva Pharm & Chem Works | Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins |
GB1539817A (en) * | 1976-10-22 | 1979-02-07 | Ucb Sa | N-substituted lactams |
-
1984
- 1984-01-23 FI FI840260A patent/FI840260A7/fi not_active Application Discontinuation
- 1984-01-23 EP EP84810040A patent/EP0115472A3/de not_active Withdrawn
- 1984-01-25 PT PT78007A patent/PT78007B/pt unknown
- 1984-01-25 IL IL70772A patent/IL70772A0/xx unknown
- 1984-01-25 GR GR73619A patent/GR81746B/el unknown
- 1984-01-25 ZA ZA84560A patent/ZA84560B/xx unknown
- 1984-01-25 DD DD84259606A patent/DD216005A5/de unknown
- 1984-01-26 NO NO840310A patent/NO840310L/no unknown
- 1984-01-26 AU AU23838/84A patent/AU2383884A/en not_active Abandoned
- 1984-01-26 DK DK35884A patent/DK35884A/da not_active Application Discontinuation
- 1984-01-26 JP JP59011110A patent/JPS59141559A/ja active Pending
- 1984-01-26 KR KR1019840000341A patent/KR840007571A/ko not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
FI840260L (fi) | 1984-07-28 |
GR81746B (cs) | 1984-12-12 |
EP0115472A3 (de) | 1985-10-02 |
EP0115472A2 (de) | 1984-08-08 |
NO840310L (no) | 1984-07-30 |
KR840007571A (ko) | 1984-12-08 |
DK35884A (da) | 1984-07-28 |
PT78007B (en) | 1986-06-18 |
ZA84560B (en) | 1984-09-26 |
DK35884D0 (da) | 1984-01-26 |
PT78007A (en) | 1984-02-01 |
FI840260A0 (fi) | 1984-01-23 |
AU2383884A (en) | 1984-08-02 |
JPS59141559A (ja) | 1984-08-14 |
IL70772A0 (en) | 1984-04-30 |
FI840260A7 (fi) | 1984-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0119161B1 (de) | Gewisse Benzazocinon- und Benzazoninon-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung | |
EP0197478B1 (de) | Neue Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0548024B1 (de) | Aminosulfonsäurederivate und Verfahren zu ihrer Herstellung | |
EP0111266A2 (de) | Substituierte Tetrapeptide | |
DD236522A5 (de) | Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen | |
DD216005A5 (de) | Verfahren zur herstellung von pyrrolidinonderivaten | |
EP0169812B1 (de) | Phosphatidylverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
EP0495750A2 (de) | Heterozyklische Hydroxylamine | |
EP0374095A2 (de) | Piperidinderivate | |
DD283807A5 (de) | Verfahren zur herstellung von cycloalkyl-substituierten glutaramid-derivaten | |
EP0099578A1 (de) | Neue Muramylpeptide und Verfahren zu ihrer Herstellung | |
EP0233837A2 (de) | Saccharidderivate und Verfahren zu ihrer Herstellung | |
DE69115135T2 (de) | 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen. | |
DE2112057A1 (de) | Neue Penicillinester | |
DE69633557T2 (de) | Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren | |
EP0115473A2 (de) | Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung | |
DE3825242A1 (de) | Durch schwefelhaltige gruppen substituierte histidinylamino-verbindungen | |
DE69019217T2 (de) | Perylenquinon (UCN-1028D)-Derivate. | |
DE19581497B4 (de) | Neue Derivate des Tetramethylcyclopropans | |
EP0174912A2 (de) | Phosphorverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE69018816T2 (de) | Aminosäurederivate. | |
DD202144A5 (de) | Verfahren zur herstellung substituierter, aliphatischer sekundaeramine | |
EP0192611A2 (de) | Acylierte Hexosederivate und Verfahren zu ihrer Herstellung | |
DE69015208T2 (de) | Glutamin- und asparginsäurederivate mit antigastrinwirkung und verfahren zu deren herstellung. | |
DE69118784T2 (de) | Neue Peptidderivate und deren pharmazeutischer Gebrauch |